HAKIM PROGRAMMABLE VALVE
Report
- Report Number
- 1226348-2014-12093
- Event Type
- Injury
- Date Received
- November 11, 2014
- Date of Event
- November 6, 2014
- Manufacturer
- CODMAN & SHURTLEFF, INC
- Product Code
- JXG
- PMA / PMN Number
- PK980778
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NC, US
- Reporter Occupation
- MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE
Narratives
UPON COMPLETION OF THE INVESTIGATION IT WAS NOTED THAT UPON A VISUAL INSPECTION, IT APPEARS THAT THE DEVICE WAS CUT. IT MIGHT ALSO BE POSSIBLE THAT IT MAY HAVE OCCURRED DURING REMOVAL AS IT WAS NOTED THAT THE DEVICE WAS INTACT WHILE IN THE PATIENT. THE VALVE AND RICHAM WERE IRRIGATED WITH PURIFIED WATER AND NO OCCLUSION WAS NOTED. THE VALVE WAS THEN DRIED AND LEAK TESTED, AND NO LEAKS WERE NOTED. THE VALVE PASSED A REFLUX TEST. THE VALVE WAS TESTED FOR PROGRAMMING. THE VALVE PASSED THE TEST. LASTLY, THE VALVE WAS PRESSURE TESTED AND THE VALVE PASSED THE TEST. REVIEW OF THE HISTORY DEVICE RECORDS CONFIRMED THE VALVE PRODUCT CODE 82-3113 WITH LOT CLDBZ1, CONFORMED TO THE SPECIFICATIONS WHEN RELEASED TO STOCK ON THE 9TH APRIL 2010. BASED ON THE RESULTS OF THIS INVESTIGATION NO FURTHER ACTION IS REQUIRED. TRENDS WILL BE MONITORED FOR THIS AND SIMILAR COMPLAINTS. AT THE PRESENT TIME THIS COMPLAINT IS CLOSED.
(B)(4). UPON COMPLETION OF THE INVESTIGATION, A FOLLOW UP REPORT WILL BE FILED.
REP REPORTED IN A PHONE CALL THAT THE VALVE WAS EXPLANTED AS THE SURGEON DID NOT BELIEVE IT WAS OPERATING AS IT SHOULD HAVE. THE PATIENT'S VENTRICLES WERE SMALL EVEN AFTER IT WAS SET AT 200MM H2O. ADDITIONALLY, THE DEVICE IS CURRENTLY DETACHED FROM THE RICKHAM, HOWEVER IT WAS REPORTED THAT THE DEVICE WAS INTACT WHILE IT WAS IMPLANTED. THE PATIENT RECEIVED THE INITIAL IMPLANT AT ANOTHER HOSPITAL.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 726035 | HAKIM PROGRAMMABLE VALVE | SHUNT, CENTRAL NERVOUS SYSTEM & COMPS | JXG | CODMAN & SHURTLEFF, INC | CLDBZ1 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |